• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Health Products Association - China Executive Director Reflects on Market Dynamics, Challenges

    Blood Sugar Management: Personalized Testing Drives Home The Need for Early Intervention

    New and Evolving Formulation Options Must Be Mindful of Blood Sugar Maintenance

    Tapping Functional Beverages to Meet Modern Wellness Needs

    Adaptogens: Where Ancient Remedies Meet Modern Wellness Products
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    CoQ10 and Royal Jelly Supplementation May Improve High Intensity Exercise

    Shiitake Mushroom Extract Appears Helpful in HPV Infections

    Fi & Hi Europe Returns with Over 20,000 Global Attendees Expected

    United Plant Savers Launches First Film Festival

    Azelis Opens Food and Nutrition Lab in Cairo, Egypt
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    CoQ10 and Royal Jelly Supplementation May Improve High Intensity Exercise

    Shiitake Mushroom Extract Appears Helpful in HPV Infections

    United Plant Savers Launches First Film Festival

    Roquette Launches Nutralys Rice Protein

    Upcycled Coffeeberry® Cascara Offers Versatility in Functional Beverage Development
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    CoQ10 and Royal Jelly Supplementation May Improve High Intensity Exercise

    Shiitake Mushroom Extract Appears Helpful in HPV Infections

    Fi & Hi Europe Returns with Over 20,000 Global Attendees Expected

    Azelis Opens Food and Nutrition Lab in Cairo, Egypt

    Florida Food Products Acquires Javo
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    CoQ10 and Royal Jelly Supplementation May Improve High Intensity Exercise

    Shiitake Mushroom Extract Appears Helpful in HPV Infections

    Upcycled Coffeeberry® Cascara Offers Versatility in Functional Beverage Development

    Botanical Gum for Kids Aims to Curb Sugar Cravings

    Combination of Collagen and Boswellia Serrata Shown to Reduce Joint Discomfort
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    JRS Pharma

    Botanic Healthcare LLC

    Verdure Sciences

    ESHA Research

    Atlantia Clinical Trials
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    JRS Pharma

    Botanic Healthcare LLC

    Verdure Sciences

    ESHA Research

    Atlantia Clinical Trials
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Online Exclusives

    Trade Groups Criticize FDA Over Latest 'Can-Kicking' CBD Report

    According to Natural Products Association and Council for Responsible Nutrition, FDA needs to step into the CBD market ASAP with its supplement rulebook.

    Trade Groups Criticize FDA Over Latest
    Currently, FDA only oversees one CBD drug, Epidiolex.
    Related CONTENT
    • Senate HELP Committee Advances Bill with Supplement Provisions That Industry Trade Groups Oppose
    • Kemin Launches Luxiva Hemp CBD Distillates
    • EFSA: Data Too Limited To Evaluate CBD as Novel Food Ingredient
    • Tapping Functional Beverages to Meet Modern Wellness Needs
    • What People Were Reading in May 2022 on NutraceuticalsWorld.com
    By Mike Montemarano, Associate Editor, Nutraceuticals World03.09.20
    One month overdue, the latest report by FDA on tentative CBD regulation provides little detail on future action, or which regulatory pathways CBD makers should take.
     
    The passage of the 2018 Farm Bill catalyzed the hemp and cannabidiol industries, which have seen explosive growth by being able to sell any hemp-derived product with less than 0.3% THC, and the whirlwind of innovations in products and delivery methods has been nonstop.
     
    How CBD will be regulated by the U.S. Food and Drug Administration (FDA) in the future remains in a state of limbo.
     
    Last year, the federal government gave FDA a 60-day time frame to provide updates on its regulatory approach to CBD, which was due in a report last month. The agency released the report on March 5.
     
    FDA provided a rundown of safety concerns regarding the use of CBD, sourced from a variety of scientific journals. Additionally, the agency voiced concern over providing consumers information on the degree to which it has the authority to regulate or oversee the marketing and quality of CBD products under its auspices.
     
    FDA has approved only one CBD drug, Epidiolex, which is used to treat two life-threatening seizure disorders in children. The agency currently takes the position that CBD should not be marketed as a food ingredient or dietary supplement. Aside from companies making egregious health claims about CBD, or committing serious violations of good manufacturing practices, the agency has not taken any administrative action against less-than-reputable companies selling or producing CBD in a problematic way.
     
    Since the 2018 Farm Bill passed, the onus has been on companies to monitor the quality, safety, and efficacy of their own products. Meanwhile, CBD manufacturers and companies are coming online at a rate which can be followed on a day-to-day basis.
     
    Latest Updates
    Among other things we’ve learned from the latest FDA report, the agency may be taking steps toward providing the public with a risk-based enforcement policy ahead of any tentative enforcement decisions. The risk-based enforcement policy would highlight the agency’s key goals that it hopes to accomplish in a regulatory structure it has not made yet.
     
    FDA also provided a rundown of the health risks it has identified thus far based on the body of research the agency is utilizing.
     
    “CBD is not a risk-free substance,” FDA said in its report. “As evidenced in the public clinical development data for Epidiolex and in the publicly available published scientific literature, CBD is associated with risks including liver injury, drug-drug interactions, drowsiness that may affect driving, and the possibility of male reproductive toxicity.
     
    The agency tallied off a number of potential risks that it hopes to address by assessing more research. Those risks include the health effects of daily CBD use for sustained periods of time, what intake levels trigger known CBD risks, how different methods of exposure affect intake, the effect of CBD on the developing brains of children, CBD’s impact on pregnancy and breastfeeding, CBD’s interaction with other herbs and botanicals, whether male reproductive toxicity occurs in humans as it did in a study on animals, and whether CBD forms residues within the edible tissues of food-producing mammals.
     
    FDA believes there are shortcomings in regulating CBD the same as any other dietary supplement, and perceives these shortcomings as a roadblock to swift action. Companies might not be required to provide “sufficient” information on what products they are making and selling to consumers. FDA is also concerned that expanding its own responsibilities to provide unique rules for CBD would adversely impact the agency’s overall workload.
     
    FDA pointed out particular concerns over CBD vape products.
     
    “FDA is concerned that CBD vapes pose public health risks in that vaping CBD raises toxicity concerns—both inherent to the substance and due to potential contaminants—and could attract children and adolescents, which are vulnerable populations,” the agency wrote.
     
    On labeling concerns, FDA reported that it wants to establish labeling guidelines for CBD products claiming to be “full spectrum” or “broad spectrum.”
     
    “We are actively seeking information from individual manufacturers, trade groups, and others regarding the processes by which ‘full spectrum’ and ‘broad spectrum’ hemp extracts are derived, what the content of such extracts is, and how these products may compare to CBD isolate products,” the agency said.
     
    Lastly, CBD researchers should know that FDA will reopen a docket from its May 2019 public meeting on CBD in order to establish a centralized, publicly-accessible place for researchers to provide new data related to safety information.
     
    In the meantime, FDA’s focus is to ensure the public understands that CBD production is essentially unregulated by any government agency at this point, and there are many unknowns in regard to its benefits and risks.
     
    “We are concerned that some people wrongly think that the myriad of CBD products on the market have been evaluated by the FDA and determined to be safe, or that using CBD ‘can’t hurt,’” The agency said in a statement.
     
    Too Little, Too Late  
    Industry trade groups believe that FDA should have developed a comprehensive regulatory plan at least a year ago, lambasted the latest update as all talk, with no regulatory oversight of CBD coming any time soon. They believe that regulations on par with other dietary supplements are more worthwhile than further debate with no foreseeable end.
     
    “The time for ‘active consideration and evaluation’ has long since passed,” the Council for Responsible Nutrition (CRN) said in a statement in response to the report. “As we’ve said before, the time for action was more than a year ago, but we will settle for now. Today’s report amounts to more bureaucratic can-kicking, and Congress should recognize it as such and take action now to declare CBD a lawful dietary ingredient. That will direct FDA to allow CBD in dietary supplements and impose that significant regulatory framework on these products.”
     
    CRN said that CBD’s safety as a standalone ingredient should no longer be on the table when the FDA could enable itself to reduce the tangential public risks.
     
    “Every day, more CBD products come to market, some from responsible manufacturers, and some from less reputable companies,” CRN continued. “By not enforcing the full range of dietary supplement regulations on this category, FDA is essentially an absentee regulator and the public is at risk. As several recent risk assessments have demonstrated, the safety of CBD as an ingredient itself is no longer an issue. However, as long as FDA ‘actively’ continues to drag its feet, the public is at risk from CBD products that may be poorly manufactured or illegally marketed. The best way to protect public health and promote market clarity is to give industry a clear pathway to market.”
     
    Daniel Fabricant, the president and CEO of the Natural Products Association (NPA) echoed the sentiment that passing CBD through as a dietary ingredient is the only way to ensure safe products.
     
    “This is more of the same from the FDA: all words and no action,” Fabricant said. “The longer FDA waits to regulate the CBD industry the greater chance we have of risking another public health crisis. Setting a safe level of consumption for CBD products is the best way to move forward with this promising new product while protecting consumers.”
     
    Related Searches
    • Nutrition
    • npa
    • Regulation
    • Regulations
    Related Knowledge Center
    • Herbs & Botanicals
    • Regulations
    • Pet Nutraceuticals
    Suggested For You
    Senate HELP Committee Advances Bill with Supplement Provisions That Industry Trade Groups Oppose Senate HELP Committee Advances Bill with Supplement Provisions That Industry Trade Groups Oppose
    Kemin Launches Luxiva Hemp CBD Distillates Kemin Launches Luxiva Hemp CBD Distillates
    EFSA: Data Too Limited To Evaluate CBD as Novel Food Ingredient EFSA: Data Too Limited To Evaluate CBD as Novel Food Ingredient
    Tapping Functional Beverages to Meet Modern Wellness Needs Tapping Functional Beverages to Meet Modern Wellness Needs
    What People Were Reading in May 2022 on NutraceuticalsWorld.com What People Were Reading in May 2022 on NutraceuticalsWorld.com
    FDA Issues Draft Guidance on NDI Enforcement Discretion FDA Issues Draft Guidance on NDI Enforcement Discretion
    Jordan Process Receives Nutrasource ICAP Certification for CBD Jordan Process Receives Nutrasource ICAP Certification for CBD
    Draft Senate Bill to Reauthorize FDA User Fees Includes Dietary Supplement Listing Provision Draft Senate Bill to Reauthorize FDA User Fees Includes Dietary Supplement Listing Provision
    Open Book Extracts Completes Phase 1 of Toxicology, Safety Assessment for Cannabinoid Ingredients Open Book Extracts Completes Phase 1 of Toxicology, Safety Assessment for Cannabinoid Ingredients
    FDA Issues Warning Letters to Companies Selling CBD, Delta-8 THC Products FDA Issues Warning Letters to Companies Selling CBD, Delta-8 THC Products
    HP Ingredients and H&AD to Showcase Ingredients at Vitafoods Europe HP Ingredients and H&AD to Showcase Ingredients at Vitafoods Europe
    James Roza of Layn Natural Ingredients: Driving the Science and Botanical Innovation James Roza of Layn Natural Ingredients: Driving the Science and Botanical Innovation
    Environmental, Social and Governance in the Cannabis Industry: A Perfect Storm is Brewing Environmental, Social and Governance in the Cannabis Industry: A Perfect Storm is Brewing
    NPA Letter Spells Out Perceived Failings of Proposed Dietary Supplement Listing Act NPA Letter Spells Out Perceived Failings of Proposed Dietary Supplement Listing Act
    Dietary Supplement Listing Bill Introduced in Senate Dietary Supplement Listing Bill Introduced in Senate

    Related Online Exclusives

    • Dietary Supplements | Regulations
      Senate HELP Committee Advances Bill with Supplement Provisions That Industry Trade Groups Oppose

      Senate HELP Committee Advances Bill with Supplement Provisions That Industry Trade Groups Oppose

      Wide-ranging ‘must-pass’ legislation heads to the full Senate for consideration.
      By Mike Montemarano, Associate Editor 06.17.22

    • Breaking News | Herbs & Botanicals | Supplier News
      Kemin Launches Luxiva Hemp CBD Distillates

      Kemin Launches Luxiva Hemp CBD Distillates

      The ingredient supplier expanded its hemp portfolio with a line of organic distillates at varying potencies.
      06.15.22

    • Breaking News | Herbs & Botanicals | Quality & Safety | Regulatory News | Research | World Markets
      EFSA: Data Too Limited To Evaluate CBD as Novel Food Ingredient

      EFSA: Data Too Limited To Evaluate CBD as Novel Food Ingredient

      In a statement issued by Europe’s foremost food safety authority, several data gaps on the safety of CBD were noted.
      06.08.22


    • Functional Foods & Beverages | Herbs & Botanicals | Mood Health & Sleep
      Tapping Functional Beverages to Meet Modern Wellness Needs

      Tapping Functional Beverages to Meet Modern Wellness Needs

      The category continues to offer new opportunities as health demands evolve, but competition and supply issues present ongoing challenges.
      By Sean Moloughney, Editor 06.02.22

    • Dietary Supplements | Regulations
      What People Were Reading in May 2022 on NutraceuticalsWorld.com

      What People Were Reading in May 2022 on NutraceuticalsWorld.com

      These were the most viewed stories in May.
      05.31.22

    Loading, Please Wait..
    Trending
    • Three Grams Of Omega-3s May Be Optimal Dose For Reducing Blood Pressure
    • 3 grams of Omega-3s May be Optimal Dose for Reducing Blood Pressu
    • Olive/Pomegranate Extract May Improve Dyslipidemia
    Breaking News
    • CoQ10 and Royal Jelly Supplementation May Improve High Intensity Exercise
    • Shiitake Mushroom Extract Appears Helpful in HPV Infections
    • Fi & Hi Europe Returns with Over 20,000 Global Attendees Expected
    • United Plant Savers Launches First Film Festival
    • Azelis Opens Food and Nutrition Lab in Cairo, Egypt
    View Breaking News >
    CURRENT ISSUE

    June 2022

    • Tapping Functional Beverages to Meet Modern Wellness Needs
    • Adaptogens: Where Ancient Remedies Meet Modern Wellness Products
    • New and Evolving Formulation Options Must Be Mindful of Blood Sugar Maintenance
    • Health Products Association - China Executive Director Reflects on Market Dynamics, Challenges
    • Blood Sugar Management: Personalized Testing Drives Home The Need for Early Intervention
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    CoQ10 and Royal Jelly Supplementation May Improve High Intensity Exercise
    Shiitake Mushroom Extract Appears Helpful in HPV Infections
    Fi & Hi Europe Returns with Over 20,000 Global Attendees Expected
    Coatings World

    Latest Breaking News From Coatings World

    H.M. Royal Becomes Exclusive OCSiAl Distributor
    American Colors to Expand Sandusky, Ohio Facility
    Vaughn O’Dea Named Director of Epoxytec
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Cepheid, BioGX Partner to Create GeneXpert Monkeypox Test
    Siemens' Varian Gains FDA IDE Nod for FAST-02 Trial
    Acutus Medical Launches AcQCross Line Extension
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Ixaka & Minaris Sign Tech Transfer & GMP Manufacturing Agreement for Cell Therapy Candidate
    Pfizer, BioNTech Adapt COVID Vax Against Omicron
    CoreRx Expands Capabilities
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Top 5 Beauty Tech Trends at Perfect Corp.'s Global Forum
    John Frieda Supports the LGBTQIA+ Community
    Athena Club Launches in Canada
    Happi

    Latest Breaking News From Happi

    Fencing Champion Bebe Vio Grandis Named Spokeswoman of L’Oréal Paris
    Past Henkel Exec Christian Chopra Named President of Scotch Porter
    Color Street Celebrates Foster, Adoption Awareness with Limited-Edition Print
    Ink World

    Latest Breaking News From Ink World

    Dr. Tammo Boinowitz to Join Management Board of ALTANA AG
    Flint Offset Packaging Solutions Announces Price Increases for Sheetfed Inks
    Weekly Recap: INX’s VC Fund, Screen Industry and Ball Top This Week’s News
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Harveer Sahni recognized with Global Achievement Award
    Color-Logic partners with Taktiful 
    ALTANA announces Management Board change
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Fibertex Personal Care Awarded EcoVadis Awards for Sustainability
    Yanpai Orders Batt Forming Equipment for Needlepunch Line
    Weekly Recap: SWM and Neenah Introduce Mativ Inc., Avgol honored for Biotransformation Technology & More
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Researchers Discover Novel Patching Material for Bone Defects
    Boston Centerless Opens Second Manufacturing Plant in Indiana
    Researchers Develop Patient-Specific 3D-Printed Smart Metamaterial Implants
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Identiv-Powered CVS Spoken Rx Wins NFC Forum 2022 Innovation Award
    LG Display Announces Winners of This Year’s OLEDs GO! Competition
    Weekly Recap: eMagin, Applied Materials, and Schott Top This Week’s Stories

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login